3rd Mastering HR Summit 2012

North West Business Group22 - 23 February 2012, Istanbul, Turkey.
The role of Human Resources is changing as fast as technology and the global marketplace. Historically, the HR department was viewed as administrative overhead.

HR processed payroll, handled benefits administration, kept personnel files and other records, managed the hiring process, and provided other administrative support to the business. Those times have changed. The positive result of these changes is that HR professionals have the opportunity to play a more strategic role in the business. The challenge for HR managers is to keep up to date with the latest HR innovations - technological, legal, and otherwise.

The 3rd Mastering HR Summit 2012 will discuss the best practices in HR management, in other words how HR managers can anticipate and address some of the most challenging HR issues this year.

The event will give you the information you need to know about these current HR challenges and how to most effectively manage them in your workplace. This forum sets a platform for practitioners from around the world to discuss and share strategies for their future success.

The event will focus on the most current topics in the HR industry such as:

  • Inclusive Talent Management as an enabler of business turnaround
  • How Connecting Performance Management & Talent is going to help you?
  • New perspectives for very experienced persons (VEPs)
  • Working with an HR Strategy to ensure employee retention & effective performance
  • Managing Talent from different cultures with a global model
  • How to connect HR investments to the firm's bottom line
  • HR Transformation and engagement - Business case
  • TQM Tools for employee empowerment
  • Motivation and benefit systems and their impact on performance - a critical view
  • How to set the strategic agenda for Human Resources

Joins some of the experts like:

  • President EAPM, Secretary General WFPMA
  • The Hertz Corporation, Vice President - Global Talent Management
  • Tetra Pak, VP Human Resources, Packaging Solutions & Cluster Coordination
  • Medtronic, Vice President Human Resources Europe & Central Asia
  • Ericsson, Vice President Human Resources & Organization
  • Beiersdorf AG, Regional HR Vice President, Asia and Australia
  • Schneider Electric France, HR Vice President Country Partner
  • Papyrus Group, Senior Vice President Human Resources
  • Citi, Senior Vice President Human Resources EMEA Consumer
  • Mercedes-Benz, General Manager – Business Support
  • Swisscom, Head Group Talent Management
  • Vodafone, Human Resources Director
  • BNP Paribas, Head of UK Recruitment & European Campus Recruitment
  • Eczacıbaşı Holding, HR Director, Corporate Human Resources
  • Gulf Bridge International, Director of HR & Corporate Planning
  • Abdiibrahim, HR Manager
  • TÜV SÜD, Former Head of Division Academy
  • And many more...

Hear from experts actively working in the industry for corporates;

  • Employing close to 1 million people.
  • Operating in more than 250 countries.
  • Presented in 6 continents.
  • With 191€ billion in revenue (2010).

This conference is designed to attract key decision makers from the HR industry with key job titles including: Managing Directors, Country Managers, General Managers, Vice Presidents, Regional Directors/ Heads, Directors, Department Heads, Managers.

Benefits of attending include:

  • Hearing from experts actively working in the industry
  • Participating in the panel discussions
  • Quizzing industry experts on the ideas that worked
  • Exchanging ideas with senior professionals across Europe

After this two day conference, you will be empowered to lead your HR team as a true strategic partner that will improve your organization's competitive advantages and sustainability.

For further information and registration, please visit:
http://nwbg.eu/all-events/3rd-master-hr-sumit-2011/

Most Popular Now

Novartis rises to second place in 2018 Access to M…

Novartis ranked second in the 2018 Access to Medicine Index (ATMi), up from 3rd place in 2016, in recognition of its long-standing efforts to improve worldwide access to ...

Sanofi builds focus on rare blood disorders and ca…

Some of the most serious unmet patient needs today are in the field of hematology. Rare blood disorders and blood-related cancers continue to be a major focus of research...

MSD is looking for a digital health solution to em…

MSD Lebanon is looking for an external partner to co-create a digital solution that helps oncologists to stay updated with relevant clinical content about cancer. The sol...

FDA approves new treatment for patients with acute…

The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for t...

Lilly submits New Drug Application to the FDA for …

Eli Lilly and Company (NYSE: LLY) has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lasmiditan for the acute...

New study reveals probiotics do not help children …

Probiotics are a multibillion-dollar industry with marketing claims of being an effective treatment for a multitude of ailments, including diarrhea. However, findings fro...

Merck and Pfizer provide update on avelumab in pla…

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxor...

U.S. FDA approves Larotrectinib, the first TRK inh…

The U.S. Food and Drug Administration (FDA) has approved larotrectinib, the first oral TRK inhibitor, under the brand name Vitrakvi®. The approval is for the treatment of...

FDA approves first treatment for Lambert-Eaton mya…

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a r...

Bristol-Myers Squibb awards "Golden Tickets…

Bristol-Myers Squibb Company (NYSE: BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, today anno...

Alcon to highlight its vision, strategy and benefi…

Alcon, the eye care division of Novartis, will today hold its first Capital Markets Day for investors and analysts in relation to the previously-announced intention of No...

FDA grants breakthrough device designation to arti…

Bayer announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Artificial Intelligence Software for Chronic Thrombo...